Clinical Trial 44657

Phoenix, AZ 85018


A Phase 3 Randomized Multicenter Study to Evaluate the Efficacy
and Safety of Open-Label Dual Therapy with Oral Vonoprazan
20 mg or Double-Blind Triple Therapy with Oral Vonoprazan
20 mg Compared to Double-Blind Triple Therapy with Oral
Lansoprazole 30 mg Daily in Patients with Helicobacter Pylori

Qualified Participants Must:

• 18+ years of age
• Dyspepsia (ie. pain or discomfort centered in the upper abdomen) lasting at least 2 weeks
• A confirmed diagnosis of functional dyspepsia
• Signs of Gerd or Erosive Esophagitis

Qualified Participants May Receive:

Study medication, study related medical care, and compensation for time and travel.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.